Ondas Raises 2026 Revenue View: Can It Deliver the Required H2 Ramp?

Ondas raised its 2026 revenue outlook to $525-$550 million and expects Q3 revenue of $140-$155 million, implying roughly 76% sequential growth at the midpoint after Q2 revenue rose more than 13-fold year over year to $83.8 million. Its reported backlog was $613 million at June 30, or $757 million pro forma including DZYNE and Cyberhawk, supporting a steep H2 delivery ramp tied to defense-drone programs. However, production scaling, supply-chain constraints, acquisition integration and competitive pressure create significant execution risk; ONDS shares have fallen 25.8% over the past month and current-year earnings estimates have been revised lower.

Analysis

ONDS is being valued as a discounted defense-drone growth story, but the discount is rational until it proves that acquired backlog carries acceptable gross margin, customer acceptance terms, and working-capital funding. The critical variable is not bookings: it is quarterly cash conversion. A production ramp of this scale can turn apparent revenue upside into inventory, receivables, and dilution before it becomes free cash flow; any Q3 revenue miss or weaker-than-expected Q4 shipment schedule would likely trigger another multiple reset.

RCAT is the cleaner tactical beneficiary of sector demand because its dedicated manufacturing buildout reduces the principal bottleneck now confronting ONDS. That does not make RCAT inexpensive or immune to program timing, but it has a more legible 1-3 month catalyst path: evidence that capacity converts into deliveries. AVAV remains the lower-beta way to own the same defense procurement cycle; its broader portfolio and established production base should capture follow-on demand if smaller suppliers fail qualification, delivery, or field-support requirements.

The contrarian point is that ONDS' relative underperformance may already reflect skepticism around the ramp, creating upside if Q3 shipments and gross margin validate execution. But the stated valuation comparison is not sufficient support: acquisition-heavy revenue deserves a lower sales multiple than organic, profitable platform revenue. Over 6-18 months, the likely winners are suppliers with repeatable production, secure component sourcing, and proven military sustainment rather than firms simply holding large order books.

Key Decisions for Investors

• Initiate a 1-3 month pair: long RCAT / short ONDS in equal dollar exposure. RCAT has the clearer capacity-validation setup, while ONDS bears integration and working-capital risk; reassess after ONDS Q3 results. Close if ONDS reports revenue within or above guidance and demonstrates stable/improving gross margin plus no material increase in receivables or inventory.
• Maintain or add AVAV as the core 6-18 month defense-autonomy exposure rather than chase smaller drone names. Use a 8-12% pullback to add; the thesis is falsified by material autonomous-systems order deceleration or a reduction in fiscal-year outlook, not by one-quarter timing noise.
• Do not establish a standalone ONDS long before Q3 unless shipment evidence, gross-margin guidance, liquidity runway, and acquisition-related purchase-accounting impacts are disclosed. If those datapoints validate, buy only as a post-results momentum position with a 15-20% downside stop; upside requires the market to re-rate execution risk, not merely accept headline revenue.
• Monitor RCAT production utilization, customer acceptance timing, and receivables at its next report. A delivery-led beat supports continuation; bookings without revenue conversion would undermine the capacity advantage and warrants reducing the long leg.